82 FR 171 pg. 42098 - B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction
Type: NOTICEVolume: 82Number: 171Page: 42098
Page: 42098Docket number: [Docket No. FDA-2017-N-4642]
FR document: [FR Doc. 2017-18813 Filed 9-5-17; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2017-N-4642]
B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a document entitled "B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application" that appeared in the Federal Register of August 3, 2017 (82 FR 36150). The document was published with the incorrect docket number. This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Lisa Granger, Office of Policy, Food and Drug Administration, Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
SUPPLEMENTARY INFORMATION:
In the Federal Register of Thursday, August 3, 2017, in FR Doc. 2017-16377, on page 36150, the following correction is made:
1. On page 36150, in the second column, in the header of the document, "Docket No. FDA-2017-N-0002" is corrected to read "Docket No. FDA-2017-N-4642".
Dated: August 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-18813 Filed 9-5-17; 8:45 am]
BILLING CODE 4164-01-P